Effects of Intravenous Acetaminophen in Patients Undergoing Thoracoscopic Surgery
Status:
Withdrawn
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
This is a single-center, randomized, double-blind, placebo-controlled trial. A total of 100
patients, 50 per treatment arm, undergoing minimally invasive thoracic surgery will be
randomized 1:1 across 2 treatment arms: Ofiramev® (acetaminophen) injection 1,000 mg (100 mL)
plus patient-controlled analgesia (PCA) and 100 mL placebo plus PCA.